Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 5/2019

01-05-2019 | Systemic Lupus Erythematosus | Letter to the Editor

Letter to the editor: “The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients”

Authors: Ilce V. Román-Fernández, José F. Muñoz-Valle, Claudia A. Palafox-Sánchez

Published in: Clinical Rheumatology | Issue 5/2019

Login to get access

Excerpt

To the editor: …
Literature
1.
2.
Román-Fernández IV, Ávila-Castillo DF, Cerpa-Cruz S, Gutiérrez-Ureña S, Hernández-Bello J, Padilla-Gutiérrez JR, Valle Y, Ramírez-Dueñas MG, Pereira-Suárez AL, Muñoz-Valle JF (2016) CD40 functional gene polymorphisms and mRNA expression in rheumatoid arthritis patients from western Mexico. Genet Mol Res 15. https://​doi.​org/​10.​4238/​gmr15048775
3.
Zhou G, Wang Y, Fang Z, Liu R, Wang A, Zhao F, Chen L (2015) CD40 -1C>T polymorphism and the risk of lung cancer in a Chinese population. Int J Clin Exp Pathol 8:15163–15169
4.
5.
6.
7.
Metadata
Title
Letter to the editor: “The association of CD40 polymorphism (rs1883832C/T) and soluble CD40 with the risk of systemic lupus erythematosus among Egyptian patients”
Authors
Ilce V. Román-Fernández
José F. Muñoz-Valle
Claudia A. Palafox-Sánchez
Publication date
01-05-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-019-04491-8

Other articles of this Issue 5/2019

Clinical Rheumatology 5/2019 Go to the issue

Case Based Review

The complexity of an overlap type resistant cryoglobulinemia: a case report and review of the literature

Brief Report

Hydroxychloroquine is a safe and effective steroid-sparing agent for immune checkpoint inhibitor–induced inflammatory arthritis

Case Based Review

Podocytic infolding glomerulopathy: two new cases with connective tissue disease and literature review

Original Article

Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers

Brief Report

Sonographic findings from inflammatory arthritis due to antisynthetase syndrome

Original Article

First trimester combined screening in patients with systemic lupus erythematosus: impact of pre-analytical variables on risk assessment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits